(Q46895531)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Adam P Mecca

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Haoyu Mao

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Michael J Katovich

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

13 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology Heart and Circulatory Physiology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

H2417-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16415071%20AND%20SRC:MED&resulttype=core&format=json

Autopotentiation of pressor responses by subpressor angiotensin II in rats.

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Myocardial infarction increases ACE2 expression in rat and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Gender differences in the attenuation of salt-induced hypertension by angiotensin (1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Mineralocorticoids and cardiac fibrosis: the decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Vascular responses to Angiotensin-(1-7) during the estrous cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Pathophysiological effects of aldosterone in cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

The renin-angiotensin system during acute myocardial ischemia in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Angiotensin-(1-7): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Pressor and subpressor angiotensin II administration. Two experimental models of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Fibrosis and hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Aldosterone and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Mineralocorticoids, hypertension, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005

Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01170.2005